FIELD: medicine, peptides.
SUBSTANCE: invention relates to biologically active peptides able to inhibit motility of cells stimulated by the chemokine MCP-1. Invention proposes peptide of the formula: H-DHLDKQTQTPKT-OH and its pharmaceutically acceptable salts. The claimed peptide can be used in cardiology for covering stents in angioplasty in aims for prophylaxis of restenosis.
EFFECT: valuable medicinal properties of peptide.
1 sch, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE DRUG | 2022 |
|
RU2827765C2 |
| PEPTIDE FOR INHIBITING FRACTALKINE-STIMULATED MIGRATION OF MONOCYTIC CELLS | 2011 |
|
RU2461565C1 |
| PEPTIDE WITH ABILITY TO INHIBIT MIGRATION OF CELLS STIMULATED BY TARC PROTEIN | 2016 |
|
RU2629198C1 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF DODECAPEPTIDE INGRAMON | 2022 |
|
RU2793124C1 |
| METHOD OF OBTAINING DODECAPEPTIDE AND TRIPEPTIDE FOR ITS REALISATION | 2007 |
|
RU2340626C1 |
| SYNTHETIC ANALOGS OF IL-10 | 1997 |
|
RU2194054C2 |
| ANTIBODIES AGAINST EOTAXIN 2, WHICH RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINES | 2015 |
|
RU2705255C2 |
| USE OF MCP-1 FOR INDUCTION OF READINESS OF UTERUS CERVIX TO OPENING | 1995 |
|
RU2207873C2 |
| ANTIBODIES RAISED TO HUMAN MCP-1 | 2001 |
|
RU2314316C2 |
| ANTIBODIES FIGHTING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND THEIR APPLICATION | 2003 |
|
RU2339647C2 |
